St. Jude Medical (NYSE:STJ) has received European regulatory approval to begin selling the next-generation version of its Epiducer lead delivery system.
Leads are wires containing electrodes that deliver electrical shocks from neurostimulators, which use electricity to block the transmission of pain signals to the brain in patients suffering from chronic pain.